South Korea and Australia on the rise as clinical research hubs
Novotech’s vice president highlighted the APAC region’s growing clinical presence, drawing attention to Australia and South Korea.
Transforming Clinical Trials
UK clinical trial sector must address prolonged timelines, say experts
UK clinical trials industry tackles recent changes in the sector
FDA issues guidance on using real-world data for drug development
FDA sketches a path for patient-focused drug development
Biosimilars: The next chapter for biologics begins
Programmatic approach: An innovative model for drug development that delivers speed and flexibility from candidate to proof-of-concept
Finding commercial success by integrating development, regulatory and market access strategies from the get-go
